Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Thymidine phosphorylase expression is associated with time to progression in patients with metastatic colorectal cancer

Open access

Abstract

BACKGROUND: 5-Fluorouracil (5-FU) is the cornerstone of chemotherapeutic treatment for patients with colorectal cancer. The enzyme thymidine phosphorylase (TP) catalyzes the conversion of 5-FU to its active metabolite, 5-fluoro-2'-deoxyuridine. TP is expressed in tumour epithelial cells and stromal cells, particularly in tumour-associated macrophages. These macrophages may affect sensitivity to chemotherapy. Previously, we identified TP as a predictive factor in microdissected tumour samples of patients with advanced colorectal cancer. In the present study, we analysed TP expression in tissues and associated stromal cells from patients with advanced colorectal cancer and associated TP levels to tumour response and time-to-event variables during first-line chemotherapy treatment. We also investigated the association between serum TP levels at the time of surgery and gene expression in primary tumour tissues. METHODS: This study included 125 patients with metastatic colorectal cancer treated with first-line 5-FU-based chemotherapy. To quantify TP gene expression levels in tumour tissues, real-time polymerase chain reaction was performed using the 7500 Fast Real-Time PCR system (Applied Biosystems, Foster City, CA, USA). TP protein concentration in matched serum samples was determined using an enzyme-linked immunosorbent assay system (USCN Life Science Inc.). RESULTS: The tumour response rate was 31%, and 30% of patients exhibited stable disease. No associations between TP expression level and age or gender were observed. Levels of TP mRNA in mucosa and tumours were positively correlated (r = 0.41, p < 0.01). No correlation between TP expression and tumour response rate was observed. Time to progression was significantly longer in patients with high TP expression (p < 0.01). Serum TP protein levels were not associated with tumour response or time-to-event variables and did not correlate with gene expression in tumour tissues. CONCLUSIONS: High TP gene expression in non-microdissected tumour tissues of patients with advanced colorectal cancer correlates with longer time to progression, which could be related to treatment. These results are in contrast to previous studies where microdissected tumour cells were analysed and may be due to the presence of adjacent stromal cells. Serum TP protein expression does not correlate to TP gene expression in tissues of patients with advanced colorectal cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1472-6890-14-25

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Patients with high thymidine phosphorylase ( TP) gene expression (n = 62, dotted line) in tumour tissues exhibited significantly longer time to progression compared with patients with low expression (n = 63, solid line).
Figure 1 Patients with high thymidine phosphorylase ( TP) gene expression (n = 62, dotted line) in tumour tissues exhibited significantly longer time to progression compared with patients with low expression (n = 63, solid line).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Research works printed but not linked: 1

  1. van Halteren HK, Peters HM, van Krieken JH, Coebergh JW, Roumen RM, van der Worp E, Wagener JT, Vreugdenhil G: Tumor growth pattern and thymidine phosphorylase expression are related with the risk of hematogenous metastasis in patients with Astler Coller B1/B2 colorectal carcinoma. Cancer. 2001, 91: 1752-1757. 10.1002/1097-0142(20010501)91:9<1752::AID-CNCR1194>3.0.CO;2-M. · doi:10.1002/1097-0142(20010501)91:9<1752::aid-cncr1194>3.0.co;2-m

Cited by

See all 22

Metadata

Authors
Lindskog, E. B., Derwinger, K., Gustavsson, B., Falk, P., & Wettergren, Y.
Affiliations
University of Gothenburg (SE)
Corresponding author
Lindskog, Elinor Bexe
Venue
BMC Clinical Pathology
Published
2014-06-10
Volume
14
Issue
1
Pages
25-25
ISSN
1472-6890 (ISSN-L)
OpenAlex
W2075758937
Cited by
22
References
36
Citations by year
2024: 1 · 2023: 2 · 2022: 5 · 2021: 2 · 2019: 3 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 3 · 2014: 1
FWCI
1.13
Type
journal article
Language
en
Open access
Locations
  • BMC Clinical Pathology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Anna-Lisa och Bror Björnssons Stiftelse
  • Cancerfonden
  • Stiftelsen Assar Gabrielssons Fond
  • Göteborgs Läkaresällskap
  • Sahlgrenska Universitetssjukhuset
Topics
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer therapeutics and mechanisms
Keywords
thymidine phosphorylase, metastatic colorectal cancer, 5-fluorouracil, time to progression, tumor stroma, tumour-associated macrophages, chemotherapy response, predictive biomarkers, first-line chemotherapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Thymidine phosphorylase expression is associated with time to progression in patients with metastatic colorectal cancer. https://app.cochat.ai/papers/10.1186/1472-6890-14-25
The paper
Lindskog, E. B., Derwinger, K., Gustavsson, B., Falk, P., & Wettergren, Y. (2014). Thymidine phosphorylase expression is associated with time to progression in patients with metastatic colorectal cancer. BMC Clinical Pathology. https://doi.org/10.1186/1472-6890-14-25

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.